AstraZeneca Expects Double-Digit Growth in Revenue and Core Earnings by 2024
AstraZeneca, the pharmaceuticals major, has projected that its revenue and core earnings per share will grow by double-digit percentages in 2024. The company recently reported its fourth-quarter results, which showed…